Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics

Ankur Butala, Melissa Shepard, Greg Pontone

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations

Abstract

Parkinson disease (PD) is a neurodegenerative disorder with a complex pathophysiology characterized by the progressive loss of dopaminergic neurons within the substantia nigra. Persons with PD experience several motoric and neuropsychiatric symptoms. Neuropsychiatric features of PD include depression, anxiety, psychosis, impulse control disorders, and apathy. In this chapter, we will utilize the National Institutes of Mental Health Research Domain Criteria (RDoC) to frame and integrate observations from two prevailing disease constructions: neurotransmitter anomalies and circuit physiology. When there is available evidence, we posit how unified translational observations may have clinical relevance and postulate importance outside of PD. Finally, we review the limited evidence available for pharmacologic management of these symptoms.

Original languageEnglish (US)
Title of host publicationHandbook of Clinical Neurology
PublisherElsevier B.V.
Pages83-121
Number of pages39
DOIs
StatePublished - 2019

Publication series

NameHandbook of Clinical Neurology
Volume165
ISSN (Print)0072-9752
ISSN (Electronic)2212-4152

Keywords

  • Anxiety
  • Apathy
  • Circuit
  • Depression
  • Impulse control
  • Parkinson disease
  • Psychopharmacology
  • Psychosis
  • RDoC

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics'. Together they form a unique fingerprint.

Cite this